This article was published originally at 420 Investor in October A highly disruptive technology that I have discussed over the past few years appears to be gaining traction. Biosynthesis,...

Librede Inc. Awarded Highly Competitive Phase II SBIR Grant from NIH February 13, 2018 CARLSBAD, Calif.–(BUSINESS WIRE)–Librede, an early stage biotechnology company, has been awarded a $1,490,000 Phase II...

There is little doubt that cannabidiol (CBD) has medicinal benefits.  Sanjay Gupta brought this into the mainstream in 2013 with his famous reversal, and, three years later, GW Pharma (NASDAQ:...

In September, the New York Times reported that THC can be produced from yeast.  It turns out that not only THC but many of the cannabinoids as well  as  terpenes...